Treating obsessive-compulsive disorder with serotonin reuptake inhibitors

Publisher： Elsevier

ISSN： 0924-977X

Source： European Neuropsychopharmacology, Vol.5, Iss.3, 1995-09, pp. : 162-163

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Fluvoxamine: a selective serotonin re-uptake inhibitor for the treatment of obsessive-compulsive disorder

By Dell’Osso Bernardo Allen Andrea Hollander Eric

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 15, 2005-12 ,pp. : 2727-2740

Informa Healthcare

Access to resources Recommend Favorite

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

By Shoja Shafti Saeed

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Aripiprazole Addition to Serotonin Reuptake Inhibitor in Treatment-Resistant Obsessive-Compulsive Disorder

Current Psychopharmacology, Vol. 3, Iss. 3, 2014-12 ,pp. : 219-225

Bentham Science Publishers

Access to resources Recommend Favorite

Advances in the pharmacotherapy of obsessive-compulsive disorder

By Bisserbe J.C.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 260-260

Elsevier

Access to resources Recommend Favorite

Pathogenetic mechanism of obsessive-compulsive disorder

By Kafka J. Paacute lovaacute E.

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 370-371

Elsevier

Access to resources Recommend Favorite